Evidence map›Paper›PMID 40505819›Full record

ArticleToxicology and applied pharmacology2025

DNA damage response inhibition is an early event in cadmium-induced breast carcinogenesis.

Alexandra N Nail, Ashley V Chavez, Aliyah N Bailey, Mayukh Banerjee, Jared L Scott, Shelia D Thomas, J Christopher States

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandra N NailDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA. Electronic address: alexandra.nail@louisville.edu.
Ashley V ChavezDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
Aliyah N BaileyDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
Mayukh BanerjeeDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
Jared L ScottDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
Shelia D ThomasDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
J Christopher StatesDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.

Funding

The role of ECM-mediated mechanosignaling on regional immunosuppression in GBMP20GM135004 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Jian Zheng · 2020 to 2026
$21.1M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Mechanism for arsenic induced carcinogenesisR01ES027778 · NIEHS · UNIVERSITY OF LOUISVILLE · PI J CHRISTOPHER STATES · 2017 to 2026
$4.3M
University of Louisville Cancer Education ProgramR25CA134283 · NCI · UNIVERSITY OF LOUISVILLE · PI HEIN, DAVID W, KIDD, LA CREIS RENEE · 2011 to 2022
$3.1M
Unraveling the molecular link between heavy metal exposure and triple-negative breast cancerK99ES036286 · NIEHS · UNIVERSITY OF LOUISVILLE · PI NAIL, ALEXANDRA NICHOLE · 2024 to 2025
$248k
NCI NIH HHS R25 CA134283NIEHS NIH HHS K99 ES036286NIEHS NIH HHS L70 ES036838NIEHS NIH HHS P30 ES030283NIEHS NIH HHS R01 ES027778NIEHS NIH HHS T32 ES011564NIGMS NIH HHS P20 GM135004
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with few treatment options that disproportionately affects individuals with Breast Cancer 1 (BRCA1) gene mutations and young, non-Hispanic Black women. However, BRCA1 mutation frequencies are similar among women from all races/ethnicities, with the exception of Ashkenazi Jewish women, suggesting that gene-environment interactions contribute to TNBC disparities. Environmental cadmium (Cd) exposure is positively associated with breast cancer and Cd accumulates in human breast tumors compared to normal adjacent tissue. Previous work determined that Cd exposure promotes MCF10A cell malignant transformation after 40 weeks. Here, we report that chronic Cd exposure dysregulates essential metal homeostasis and promotes significant accumulation of DNA double-strand breaks (DSBs). Moreover, phosphorylation of Breast Cancer gene 1 (BRCA1) and Tumor Protein P53 (TP53) at critical sites (pSer1524 and pSer392, respectively) required for DNA damage response (DDR) signaling were significantly reduced by chronic Cd exposure in pre-malignant MCF10A cells. We also demonstrate significantly lower cyclin dependent kinase inhibitor 1A (CDKN1A) expression and increased RB1 phosphorylation (pSer807/811), providing evidence for reduced BRCA1 and/or TP53 function in cells chronically exposed to Cd. Our results suggest that chronic Cd exposure inhibits DDR signaling both indirectly by depletion of essential metals and by inhibition of DDR zinc finger protein activation, providing novel mechanisms for environmentally-induced TNBC. As a result, our study provides a molecular mechanism that may contribute to TNBC disparities.

Indexed as

CadmiumDNA DamageTriple Negative Breast NeoplasmsBRCA1 ProteinCell Line, TumorCyclin-Dependent Kinase Inhibitor p21DNA Breaks, Double-StrandedEnvironmental ExposureEpithelial CellsFemaleHumansRetinoblastoma Binding ProteinsTumor Suppressor Protein p53Ubiquitin-Protein LigasesBRCA1 ProteinBRCA1 protein, humanCadmiumCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21RB1 protein, humanRetinoblastoma Binding ProteinsTP53 protein, humanTumor Suppressor Protein p53Ubiquitin-Protein LigasesBreast cancerCadmiumCell cycleDNA damage response

Identifiers

PMID40505819
PMCPMC12422750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.